Multimorbidity: Priorities and Deprescribing in Prac... \| MDster show = false, 1500)" role="region" aria-label="Connection status" aria-atomic="true" x-bind:aria-live="offline ? 'assertive' : 'polite'" x-bind:aria-hidden="(!show).toString()" class="offline-banner max-w-sm mx-auto px-4 py-3 text-sm font-bold text-center text-white rounded-full shadow-lg transition-all duration-500 ease-in-out" :class="{ 'hidden-state': !show, 'bg-error': offline, 'bg-success': !offline }"> You are offline Back online! [ MDster home ](/ "MDster home") Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Neurology ](https://mdster.com/speciality/neurology) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ SOE Examiner NEW ](https://mdster.com/soe-examiner) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) Menu Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Neurology ](https://mdster.com/speciality/neurology) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ SOE Examiner NEW ](https://mdster.com/soe-examiner) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) [ Login ](https://mdster.com/auth/login) 1. [ Home ](https://mdster.com) 2. [ Blog ](https://mdster.com/blog) 3. [ Medical Education ](https://mdster.com/blog?category=medical-education) 4. Multimorbidity and Competing Priorities: What to Treat First [ Medical Education ](https://mdster.com/blog?category=medical-education) Multimorbidity and Competing Priorities: What to Treat First ============================================================== A practical framework for balancing risk, patient goals, time-to-benefit, and treatment burden in Family Medicine. [ MDster Editorial Team ](https://mdster.com/about) · Nov 09, 2026 · 6 min read · 58 [ Reviewed by Dr. Ali Ragab, MBBCH, MSc, MCAI ](https://mdster.com/medical-reviewers/dr-ali-ragab) [Editorial Policy](https://mdster.com/editorial-policy) \| [Corrections Policy](https://mdster.com/corrections) [ Family Medicine ](https://mdster.com/blog?tag=family-medicine) [ Chronic Care Management ](https://mdster.com/blog?tag=chronic-care-management) [ Shared Decision-Making ](https://mdster.com/blog?tag=shared-decision-making) [ Deprescribing ](https://mdster.com/blog?tag=deprescribing) [ Multimorbidity ](https://mdster.com/blog?tag=multimorbidity) ![Multimorbidity and Competing Priorities: What to Treat First](https://mdster.com/storage/blog/images/multimorbidity-and-competing-priorities-what-to-treat-first.png) Share this article Share this post On this page 1. [ Start With Competing Outcomes ](#start-with-competing-outcomes) 2. [ Ask what matters before adjusting targets ](#ask-what-matters-before-adjusting-targets) 3. [ Use Time-to-Benefit Without Turning It Into a Stopwatch ](#use-time-to-benefit-without-turning-it-into-a-stopwatch) 4. [ Separate prevention from protection already needed ](#separate-prevention-from-protection-already-needed) 5. [ De-intensify Deliberately, Not Reflexively ](#de-intensify-deliberately-not-reflexively) 6. [ Recognize triggers—and protect against undertreatment ](#recognize-triggers-and-protect-against-undertreatment) 7. [ Make the Plan Livable ](#make-the-plan-livable) 8. [ Turn shared decisions into a follow-up contract ](#turn-shared-decisions-into-a-follow-up-contract) 9. [ Board-exam traps ](#board-exam-traps) 10. [ Key Takeaways ](#key-takeaways) 11. [ Frequently Asked Questions ](#blog-faqs) 12. [ References ](#references-heading) On this page 1. [ Start With Competing Outcomes ](#start-with-competing-outcomes) 2. [ Ask what matters before adjusting targets ](#ask-what-matters-before-adjusting-targets) 3. [ Use Time-to-Benefit Without Turning It Into a Stopwatch ](#use-time-to-benefit-without-turning-it-into-a-stopwatch) 4. [ Separate prevention from protection already needed ](#separate-prevention-from-protection-already-needed) 5. [ De-intensify Deliberately, Not Reflexively ](#de-intensify-deliberately-not-reflexively) 6. [ Recognize triggers—and protect against undertreatment ](#recognize-triggers-and-protect-against-undertreatment) 7. [ Make the Plan Livable ](#make-the-plan-livable) 8. [ Turn shared decisions into a follow-up contract ](#turn-shared-decisions-into-a-follow-up-contract) 9. [ Board-exam traps ](#board-exam-traps) 10. [ Key Takeaways ](#key-takeaways) 11. [ Frequently Asked Questions ](#blog-faqs) 12. [ References ](#references-heading) A 79-year-old with diabetes, CKD, and hypertension arrives with an A1c of 6.4%, dizziness on standing, and a medication list that takes ten minutes to reconcile. Each disease-specific target looks reassuring. The patient’s actual priority is staying independent without another fall. **Treat the person’s risk, not the neatness of the numbers.** Start With Competing Outcomes ----------------------------- ### Ask what matters before adjusting targets Multimorbidity changes the question from “Is each condition controlled?” to “Which action is most likely to help this person?” Ask what the patient wants to keep doing, what they fear, and which tasks of care they find hardest. Independence, stroke prevention, symptom relief, and fewer appointments may carry different weights for different patients. NICE recommends building an individualized plan around those priorities, disease burden, and treatment burden rather than simply stacking single-condition guidelines. [\[1\]](#cite-1 "Reference [1]") Then rank decisions by **immediacy, magnitude of benefit, and burden**: - Address near-term threats first: hypoglycemia, symptomatic hypotension, falls, bleeding, or worsening heart failure. - Preserve treatments with meaningful symptom relief or cardiovascular and kidney benefit when their benefits remain relevant to the patient. - Reconsider interventions aimed chiefly at preventing a distant event if their burden is substantial and benefit is unlikely within the patient’s expected lifespan. Do not equate older age with limited life expectancy. Function, frailty, comorbidity severity, and patient preference matter more than a birthday. Equally, do not assume a patient can manage separate plans from three specialists without help. [\[1\]](#cite-1 "Reference [1]") Use Time-to-Benefit Without Turning It Into a Stopwatch ------------------------------------------------------- ### Separate prevention from protection already needed Time-to-benefit asks how long treatment generally takes to produce a worthwhile outcome. Harms such as dizziness, hypoglycemia, cost, and monitoring demands can begin much sooner. In a meta-analysis of primary-prevention statin trials involving adults aged 50–75, treating 100 people for approximately 2.5 years prevented one major cardiovascular event. That estimate is **not** a rule for stopping statins after a myocardial infarction, nor is it a precise prediction for an individual older than 75. [\[2\]](#cite-2 "Reference [2]") Apply the distinction at the bedside. A burdensome primary-prevention drug may be a reasonable candidate for discussion when prognosis is limited; a treatment preventing current symptoms or recurrent events deserves a different assessment. Revisit the indication before removing a medication: the same drug may serve more than one purpose, and the patient may value those purposes differently. [\[1\]](#cite-1 "Reference [1]") > **Clinical Pearl:** When a patient says, “I take too many pills,” ask which pill, appointment, injection, or side effect costs them the most. Pill count alone misses treatment burden. [\[1\]](#cite-1 "Reference [1]") De-intensify Deliberately, Not Reflexively ------------------------------------------ ### Recognize triggers—and protect against undertreatment Falls, recurrent hypoglycemia, orthostatic symptoms, declining cognition or function, reduced oral intake, a new care setting, and a medication without a clear current indication should trigger review. They do not automatically justify stopping every preventive treatment. In older adults with diabetes, the ADA recommends de-intensifying hypoglycemia-causing drugs when risk is high and simplifying complex insulin plans when burdens outweigh benefits. For very complex health, avoiding hypoglycemia and symptomatic hyperglycemia matters more than chasing a stringent A1c. [\[3\]](#cite-3 "Reference [3]") Do not confuse an excellent A1c with an excellent regimen. Recurrent lows on insulin or a sulfonylurea warrant action even when the average glucose looks acceptable. Conversely, a patient with type 2 diabetes and heart failure or CKD may still benefit from an appropriately selected cardiorenal-protective agent irrespective of A1c; review its indication and tolerability rather than labeling every diabetes drug expendable. [\[3\]](#cite-3 "Reference [3]") For the dizzy patient in the opening scenario, check orthostatic BP, falls history, home readings, intake, and each drug’s indication before changing antihypertensives. If reduction is appropriate, choose a candidate, change one medication at a time, and arrange BP and symptom follow-up. The OPTiMISE trial supports the feasibility of removing one antihypertensive in selected adults aged 80 or older with controlled BP, but its short-term results do not establish safety for every frail patient or every drug indication. [\[4\]](#cite-4 "Reference [4]") Make the Plan Livable --------------------- ### Turn shared decisions into a follow-up contract Treatment burden includes travel, copays, monitoring, complicated schedules, dietary rules, and care-partner work—not just adverse drug effects. Ask the patient to describe an ordinary week of care. Coordinate visits and reconcile specialist recommendations so that one clinician owns the overall plan. NICE explicitly includes appointment burden and coordination in multimorbidity review. [\[1\]](#cite-1 "Reference [1]") Use a short, reversible deprescribing plan: 1. Confirm the indication, likely benefit, current harm, and the patient’s goal. 2. Agree on one change and explain what improvement—or deterioration—to watch for. 3. Set a review point, document who will monitor it, and specify when to call or restart treatment. ### Board-exam traps - Do not intensify diabetes treatment solely because a standard A1c target has not been met; individualize the target to health status and hypoglycemia risk. [\[5\]](#cite-5 "Reference [5]") - Do not stop a statin simply because a patient is old; distinguish primary from secondary prevention. [\[2\]](#cite-2 "Reference [2]") - Do not treat deprescribing as abandonment. Monitoring and a plan to reverse course are part of the intervention. [\[1\]](#cite-1 "Reference [1]") Key Takeaways ------------- - Prioritize immediate harm, meaningful benefit, and the patient’s stated goals over isolated disease targets. - Compare time-to-benefit with prognosis, but avoid applying population estimates mechanically. - Treat hypoglycemia, falls, and treatment burden as prompts to review—not excuses for indiscriminate stopping. - Make one agreed change, monitor its effects, and keep the plan coordinated. Good chronic care is not the longest medication list or the lowest laboratory value. It is a plan the patient can live with that protects the outcomes they value most. Frequently Asked Questions ---------------------------- ### Does a low A1c mean an older adult should stop diabetes medication? Not by itself. Review hypoglycemia, function, treatment burden, and each drug’s other benefits; reduce high-risk therapy when harms outweigh benefits within an individualized goal. ### When is time-to-benefit most useful in a medication review? Use it when weighing preventive treatment against limited prognosis or substantial present-day burden. Do not apply a primary-prevention estimate to secondary prevention. ### What should I check before reducing an antihypertensive in a patient who falls? Assess orthostatic and home BP, symptoms, volume status, and every drug’s indication. If reduction is appropriate, change one drug and arrange follow-up. ### How can a practice reduce treatment burden without withdrawing beneficial therapy? Ask which tasks are hardest, simplify schedules where possible, coordinate appointments, and agree on a single care plan with clear monitoring responsibilities. References (5) ------------------ 1. 1. [ NICE. Multimorbidity: clinical assessment and management (NG56). ](https://www.nice.org.uk/guidance/ng56/chapter/Recommendations) [↩](#cite-ref-1-1 "Back to text") 2. 2. [ Evaluation of Time to Benefit of Statins for Primary Prevention. JAMA Internal Medicine, 2021. ](https://pmc.ncbi.nlm.nih.gov/articles/PMC7670393/) [↩](#cite-ref-2-1 "Back to text") 3. 3. [ American Diabetes Association. Older Adults: Standards of Care in Diabetes—2026. ](https://diabetesjournals.org/care/article/49/Supplement_1/S277/163921/13-Older-Adults-Standards-of-Care-in-Diabetes-2026) [↩](#cite-ref-3-1 "Back to text") 4. 4. [ OPTiMISE randomized clinical trial. JAMA, 2020. ](https://pubmed.ncbi.nlm.nih.gov/32453368/) [↩](#cite-ref-4-1 "Back to text") 5. 5. [ diabetesjournals.org/care/article/49/Supplement\_1/S277/163928/13-Older-Adults-Standards-of-Care-in-Diabetes-2026 ](https://diabetesjournals.org/care/article/49/Supplement_1/S277/163928/13-Older-Adults-Standards-of-Care-in-Diabetes-2026) [↩](#cite-ref-5-1 "Back to text") Keep going Stay consistent in Family Medicine prep with a guided pathway --------------------------------------------------------------- - Broad coverage without the overwhelm - Short daily sessions that compound - See your progress and focus on weak areas [ Start practicing ](https://mdster.com/user/dashboard) [ Explore Family Medicine ](https://mdster.com/speciality/family-medicine) [ View pricing ](https://mdster.com/pricing) [ Explore features ](https://mdster.com/features) No credit card required. Full access to all features\*. No commitment. Cancel anytime. \*AI SOE Examiner is limited to 10 cases monthly for Advanced & Bundle subscribers. Explore topics: [ # Family Medicine ](https://mdster.com/blog?tag=family-medicine) [ # Chronic Care Management ](https://mdster.com/blog?tag=chronic-care-management) [ # Shared Decision-Making ](https://mdster.com/blog?tag=shared-decision-making) [ # Deprescribing ](https://mdster.com/blog?tag=deprescribing) [ # Multimorbidity ](https://mdster.com/blog?tag=multimorbidity) [ Back to all posts ](https://mdster.com/blog) Discussion () ----------------- Join the discussion [ Log in ](https://mdster.com/auth/login) or [ Sign up ](https://mdster.com/auth/register) No comments yet Be the first to share your thoughts! ![]() More in Medical Education ------------------------- [ See all ](https://mdster.com/blog?category=medical-education) [### Sequential Testing Strategy: Bayesian Reasoning Without Redundant Tests 5 min read Nov 08, 2026 ](https://mdster.com/blog/sequential-testing-strategy-bayesian-reasoning-without-redundant-tests) [### Parasomnias vs Nocturnal Seizures in Children: A Practical Guide 6 min read Nov 07, 2026 ](https://mdster.com/blog/parasomnias-vs-nocturnal-seizures-in-children-a-practical-guide) [### Endometriosis Surgery: Practical Principles for Generalist OB-GYNs 6 min read Nov 06, 2026 ](https://mdster.com/blog/endometriosis-surgery-practical-principles-for-generalist-ob-gyns) Related Posts ------------- [ ![Sequential Testing Strategy: Bayesian Reasoning Without Redundant Tests](https://mdster.com/storage/blog/images/sequential-testing-strategy-bayesian-reasoning-without-redundant-tests.png) Medical Education ### Sequential Testing Strategy: Bayesian Reasoning Without Redundant Tests Learn to update disease probability across diagnostic tests, recognize conditional dependence, and stop testing when another result will not change patient care. 5 min read 0 comments ](https://mdster.com/blog/sequential-testing-strategy-bayesian-reasoning-without-redundant-tests) [ ![Parasomnias vs Nocturnal Seizures in Children: A Practical Guide](https://mdster.com/storage/blog/images/parasomnias-vs-nocturnal-seizures-in-children-a-practical-guide.png) Medical Education ### Parasomnias vs Nocturnal Seizures in Children: A Practical Guide A child’s nighttime movements may be a parasomnia or a seizure. Learn which history and video clues matter, when EEG testing helps, and how to counsel families about safety. 6 min read 0 comments ](https://mdster.com/blog/parasomnias-vs-nocturnal-seizures-in-children-a-practical-guide) [ ![Endometriosis Surgery: Practical Principles for Generalist OB-GYNs](https://mdster.com/storage/blog/images/endometriosis-surgery-practical-principles-for-generalist-ob-gyns.png) Medical Education ### Endometriosis Surgery: Practical Principles for Generalist OB-GYNs A practical guide to endometriosis surgery: when to operate, how excision differs from ablation, and how to limit ovarian and organ injury. 6 min read 0 comments ](https://mdster.com/blog/endometriosis-surgery-practical-principles-for-generalist-ob-gyns) [ ![Chronic Disease Palliative Integration in Family Medicine](https://mdster.com/storage/blog/images/chronic-disease-palliative-integration-in-family-medicine.png) Medical Education ### Chronic Disease Palliative Integration in Family Medicine A practical approach to symptom relief, serious illness conversations, caregiver support, and hospice decisions in cancer survivorship and chronic infection care. 6 min read 0 comments ](https://mdster.com/blog/chronic-disease-palliative-integration-in-family-medicine) [ ![Bias Mitigation in Clinical Decisions: Prevent Delays and Undertreatment](https://mdster.com/storage/blog/images/bias-mitigation-in-clinical-decisions-prevent-delays-and-undertreatment.png) Medical Education ### Bias Mitigation in Clinical Decisions: Prevent Delays and Undertreatment Learn how to interrupt diagnostic delay, assess pain without stereotyping, and use shared decision-making to make safer clinical decisions across patient populations. 5 min read 0 comments ](https://mdster.com/blog/bias-mitigation-in-clinical-decisions-prevent-delays-and-undertreatment) [ ![Pediatric After-Death Care and Legal Documentation: A Practical Guide](https://mdster.com/storage/blog/images/pediatric-after-death-care-and-legal-documentation-a-practical-guide.png) Medical Education ### Pediatric After-Death Care and Legal Documentation: A Practical Guide A practical pediatric guide to confirming death, writing a useful record, recognizing medical examiner cases, coordinating donation, and supporting families. 6 min read 0 comments ](https://mdster.com/blog/pediatric-after-death-care-and-legal-documentation-a-practical-guide) [ MDster home ](/ "MDster home") Master your medical exams with evidence-based learning. [ Download on the App Store ](https://apps.apple.com/app/id6759168258) [ GET IT ON Google Play ](https://play.google.com/store/apps/details?id=com.mdster.app) Platform - [Home](https://mdster.com) - [Features](https://mdster.com/features) - [Pricing](https://mdster.com/pricing) - [About](https://mdster.com/about) Resources - [Blog](https://mdster.com/blog) - [Curriculum](https://mdster.com/curriculum) - [Dashboard](https://mdster.com/user/dashboard) Support - [Contact](https://mdster.com/contact) - [Legal & Policies](https://mdster.com/legal) - [Medical Reviewers](https://mdster.com/medical-reviewers) © 2026 MDster [Terms](https://mdster.com/terms) [Privacy](https://mdster.com/privacy) [Editorial](https://mdster.com/editorial-policy) [ ](https://apps.apple.com/app/id6759168258) [ ](https://play.google.com/store/apps/details?id=com.mdster.app) reCAPTCHA Protected by reCAPTCHA. Google [Privacy Policy](https://policies.google.com/privacy) and [Terms of Service](https://policies.google.com/terms) apply. Cookie Consent -------------- We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. [ Terms of Use ](https://mdster.com/terms) & [ Privacy Policy ](https://mdster.com/privacy) Accept